Janus Henderson Group PLC Sanofi Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Sanofi stock. As of the latest transaction made, Janus Henderson Group PLC holds 881,682 shares of SNY stock, worth $42.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

881,682

Previous 789,667 11.65%

Holding current value

$42.5 Million

Previous $38.3 Million 32.69%

% of portfolio

0.03%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$48.54 - $58.53 $4.47 Million - $5.39 Million	92,015 Added 11.65%	881,682 $50.8 Million
Q2 2024 Aug 14, 2024	BUY	$45.39 - $50.36 $9.91 Million - $11 Million	218,413 Added 38.23%	789,667 $38.3 Million
Q1 2024 May 15, 2024	SELL	$45.75 - $52.48 $4.07 Million - $4.67 Million	-88,944 Reduced 13.47%	571,254 $27.8 Million
Q4 2023 Feb 14, 2024	SELL	$43.13 - $54.79 $5.04 Million - $6.4 Million	-116,812 Reduced 15.03%	660,198 $32.8 Million
Q3 2023 Nov 14, 2023	BUY	$50.95 - $55.2 $617,615 - $669,134	12,122 Added 1.58%	777,010 $41.7 Million
Q2 2023 Aug 14, 2023	BUY	$50.45 - $57.18 $2.78 Million - $3.15 Million	55,130 Added 7.77%	764,888 $41.2 Million
Q1 2023 May 15, 2023	BUY	$45.86 - $54.45 $433,055 - $514,171	9,443 Added 1.35%	709,758 $38.6 Million
Q4 2022 Feb 14, 2023	BUY	$38.86 - $48.55 $4.26 Million - $5.32 Million	109,647 Added 18.56%	700,315 $33.9 Million
Q3 2022 Nov 14, 2022	BUY	$37.22 - $100.5 $544,863 - $1.47 Million	14,639 Added 2.54%	590,668 $22.5 Million
Q2 2022 Aug 15, 2022	BUY	$48.99 - $57.46 $1.1 Million - $1.29 Million	22,533 Added 4.07%	576,029 $28.8 Million
Q1 2022 May 16, 2022	BUY	$48.48 - $53.65 $894,601 - $990,003	18,453 Added 3.45%	553,496 $28.4 Million
Q4 2021 Feb 14, 2022	SELL	$47.07 - $52.35 $1.5 Million - $1.66 Million	-31,789 Reduced 5.61%	535,043 $26.8 Million
Q3 2021 Nov 16, 2021	SELL	$47.89 - $53.12 $1.71 Million - $1.89 Million	-35,658 Reduced 5.92%	566,832 $27.3 Million
Q2 2021 Aug 16, 2021	BUY	$49.36 - $54.25 $1.09 Million - $1.2 Million	22,154 Added 3.82%	602,490 $31.7 Million
Q1 2021 May 17, 2021	BUY	$45.46 - $50.51 $2.63 Million - $2.92 Million	57,745 Added 11.05%	580,336 $28.7 Million
Q4 2020 Feb 16, 2021	SELL	$45.3 - $51.62 $317,688 - $362,011	-7,013 Reduced 1.32%	522,591 $25.4 Million
Q3 2020 Nov 16, 2020	BUY	$49.47 - $53.77 $2.37 Million - $2.58 Million	47,956 Added 9.96%	529,604 $26.6 Million
Q2 2020 Aug 14, 2020	BUY	$42.91 - $52.5 $1.22 Million - $1.49 Million	28,389 Added 6.26%	481,648 $24.6 Million
Q1 2020 May 14, 2020	SELL	$38.02 - $51.66 $509,468 - $692,244	-13,400 Reduced 2.87%	453,259 $19.8 Million
Q4 2019 Feb 18, 2020	SELL	$44.25 - $50.86 $2.25 Million - $2.59 Million	-50,849 Reduced 9.83%	466,659 $23.4 Million
Q3 2019 Nov 14, 2019	SELL	$40.34 - $46.64 $628,456 - $726,604	-15,579 Reduced 2.92%	517,508 $24 Million
Q2 2019 Jul 31, 2019	BUY	$40.43 - $44.3 $569,820 - $624,364	14,094 Added 2.72%	533,087 $23.1 Million
Q1 2019 Apr 30, 2019	BUY	$40.83 - $45.43 $1.69 Million - $1.88 Million	41,296 Added 8.64%	518,993 $23 Million
Q4 2018 Feb 06, 2019	SELL	$41.48 - $45.59 $645,511 - $709,471	-15,562 Reduced 3.15%	477,697 $20.7 Million
Q3 2018 Nov 09, 2018	BUY	$40.0 - $44.84 $419,800 - $470,595	10,495 Added 2.17%	493,259 $22 Million
Q2 2018 Aug 10, 2018	SELL	$37.63 - $41.22 $551,542 - $604,161	-14,657 Reduced 2.95%	482,764 $19.3 Million
Q1 2018 May 14, 2018	SELL	$38.98 - $45.76 $262,179 - $307,781	-6,726 Reduced 1.33%	497,421 $19.9 Million
Q4 2017 Feb 09, 2018	SELL	$42.86 - $50.61 $745,935 - $880,816	-17,404 Reduced 3.34%	504,147 $21.7 Million
Q3 2017 Nov 14, 2017	BUY	$47.04 - $50.34 $2.39 Million - $2.55 Million	50,720 Added 10.77%	521,551 $0
Q2 2017 Aug 17, 2017	BUY	N/A	470,831	470,831 $22.6 Million

Others Institutions Holding SNY

# of Institutions

822

Shares Held

268M

Call Options Held

Put Options Held

1.9M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Sanofi Transaction History